Carfilzomib is an injectable drug that blocks the ability of cancer cells to produce and destroy proteins, preventing them from multiplying rapidly, which slows the development of cancer.
Thus, this remedy is used in combination with dexamethasone and lenalidomide to treat cases of multiple myeloma, a type of cancer of the bone marrow.
The trade name for this drug is Kyprolis and although it may be purchased from conventional pharmacies with a prescription, it should only be given in the hospital under the supervision of a doctor experienced in the treatment of cancer.
What is it for
This medication is indicated for the treatment of adults with multiple myeloma who have received at least one type of previous treatment. Carfilzomib should be used in combination with dexamethasone and lenalidomide.
How to use
Carfilzomib can only be administered in the hospital by a doctor or nurse, and the recommended dose varies according to the body weight of each person and the body's response to treatment
This medicine should be administered directly into the vein for 10 minutes on two days in a row, once a week, and for 3 weeks. After these weeks you should take a break of 12 days and start another cycle if necessary.
Possible side effects
Some of the most common side effects include dizziness, headaches, insomnia, decreased appetite, increased blood pressure, feeling short of breath, coughing vomiting, diarrhea, constipation, abdominal pain, nausea, joint pain, muscle spasms, excessive tiredness and even fever,
In addition, there may also be cases of pneumonia and other constant respiratory infections, as well as changes in blood test values, especially in the number of leukocytes, erythrocytes and platelets.
Who should not use
Carfilzomib should not be used by pregnant or nursing women as well as in people who are allergic to any of the ingredients in the formula. In addition, it should be used with care and only under medical advice in case of heart disease, lung problems or kidney changes.
